000 01376 a2200385 4500
005 20250517162830.0
264 0 _c20190701
008 201907s 0 0 eng d
022 _a0001-5385
024 7 _a10.1080/00015385.2017.1319681
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClaeys, Marc J
245 0 0 _aSummary of 2016 ESC guidelines on heart failure, atrial fibrillation, dyslipidaemia and cardiovascular prevention.
_h[electronic resource]
260 _bActa cardiologica
_cDec 2017
300 _a610-615 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAtrial Fibrillation
_xprevention & control
650 0 4 _aCongresses as Topic
650 0 4 _aDisease Management
650 0 4 _aDyslipidemias
_xprevention & control
650 0 4 _aEurope
650 0 4 _aHeart Failure
_xprevention & control
650 0 4 _aHumans
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPrimary Prevention
_xmethods
650 0 4 _aRetrospective Studies
650 0 4 _aSocieties, Medical
700 1 _aMullens, Wilfried
700 1 _aVandekerckhove, Yves
700 1 _aDuytschaever, Mattias
700 1 _aDe Maeyer, Catherine
700 1 _aPasquet, Agnes
773 0 _tActa cardiologica
_gvol. 72
_gno. 6
_gp. 610-615
856 4 0 _uhttps://doi.org/10.1080/00015385.2017.1319681
_zAvailable from publisher's website
999 _c27346252
_d27346252